Brief: Genexine Announces Merger With EPD Biotherapeutics
04/07/2024 11:32
July 4 (Reuters) - Genexine Inc 095700.KQ :
* GENEXINE ANNOUNCES MERGER WITH EPD BIOTHERAPEUTICS TO
STRENGTHEN
DRUG DEVELOPMENT PIPELINE
* GENEXINE INC: MERGER RATIO IS 1:6.1924079, GENEXINE WILL
ISSUE
NEW SHARES TO EXISTING SHAREHOLDERS OF EPD BIO
Source text for Eikon: ID:nBw8WFlxFa
Further company coverage: 095700.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genexine
See all newsBrief: Genexine Announces Merger With EPD Biotherapeutics
Brief: Genexine To Invest 29 Billion Won As Part Of Consortium In Building New Research And Development Centre In Seoul, South Koreａ
Brief: Genexine To Divest 19 Billion Won Worth Of Shares In Ajinomoto Genexine Co
Brief: Genexine Receives Fast Track Designation From Korean Health Authority For Vaccine For Advanced Cervical Cancer
Indonesia in talks with WHO to become global vaccine hub: minister